上海赛伦生物技术股份有限公司2025年第三季度报告

Core Points - The company, Shanghai Sailun Biotechnology Co., Ltd., ensures the authenticity, accuracy, and completeness of the quarterly report, with all board members and senior management bearing legal responsibility for any misrepresentation or omissions [2][7] - The quarterly financial statements are not audited, indicating that the financial data may not have undergone a thorough external review [3][6] - The report includes a statement regarding non-recurring gains and losses, but it is noted that there are no significant changes in the financial indicators or major accounting data [4][5] Financial Data - The financial statements for the period ending September 30, 2025, are prepared in RMB and are unaudited [6][7] - The report mentions that there were no profits recorded from mergers under common control for the current or previous periods, with both showing a net profit of 0 yuan [6]